Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00040183
Status:
COMPLETED
Last Update Posted:
2018-01-10
First Post:
2002-06-21
Brief Title:
OSI-774 Tarceva Plus Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Sponsor:
OSI Pharmaceuticals
Organization:
Astellas Pharma Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pancreatic Cancer |
Keywords:
| Name | View |
|---|---|
| Tarceva EGFR erlotinib OSI-774 | View |